feed,title,long_url,short_url
InsiderMonkey,10 Stocks Surprise Wall Street with Double-Digit Gains,https://insidermonkey.com/blog/--1576887,
InsiderMonkey,TOYO Co (TOYO) Released its Updated Financial Report for 2024,https://insidermonkey.com/blog/--1576400,
InsiderMonkey,Tuya Inc. (TUYA) co-hosted The Global Telecom AIoT Summit 2025,https://insidermonkey.com/blog/--1576401,
InsiderMonkey,Health In Tech (HIT) Announced Results for its Fiscal Second Quarter of 2025,https://insidermonkey.com/blog/--1576403,
InsiderMonkey,Cronos Group (CRON) Expands its Reach to Europe with a New Partnership,https://insidermonkey.com/blog/--1576405,
InsiderMonkey,"RBC Capital Lowered the PT on MannKind Corporation (MNKD), Kept a Buy Rating",https://insidermonkey.com/blog/--1576408,
InsiderMonkey,Kepler Capital Maintained a Buy Rating on Genfit (GNFT),https://insidermonkey.com/blog/--1576409,
InsiderMonkey,"Maxim Group Lowered the PT on Intchains Group Limited, Kept a Buy Rating",https://insidermonkey.com/blog/--1576411,
InsiderMonkey,Kepler Capital Remains Bullish on Novo Nordisk A/S (NVO),https://insidermonkey.com/blog/--1576181,
InsiderMonkey,TD Cowen Maintains a Buy on Stryker Corporation (SYK) With a $435 PT,https://insidermonkey.com/blog/--1576182,
InsiderMonkey,"Mizuho Lifts PT on Medtronic (MDT) to $100 From $98, Keeps an Outperform Rating",https://insidermonkey.com/blog/--1576183,
InsiderMonkey,Goldman Sachs Maintains a Hold on Bristol-Myers Squibb (BMY),https://insidermonkey.com/blog/--1576184,
InsiderMonkey,BofA Reiterates a Sell Rating on Amgen (AMGN),https://insidermonkey.com/blog/--1576185,
InsiderMonkey,"Leerink Partners Decreases PT on Abbott Laboratories (ABT) to $136 From $143, Maintains a Hold Rating",https://insidermonkey.com/blog/--1576186,
InsiderMonkey,Citi Maintains a Buy Rating on Gilead Sciences (GILD),https://insidermonkey.com/blog/--1576187,
InsiderMonkey,Guggenheim Reiterates a Buy Rating on AbbVie (ABBV) With a $216 PT,https://insidermonkey.com/blog/--1576188,
InsiderMonkey,Leerink Partners Slashes PT on Merck & Co. (MRK) to $92 From $115,https://insidermonkey.com/blog/--1576190,
InsiderMonkey,Morgan Stanley Maintains a Hold on Pfizer (PFE),https://insidermonkey.com/blog/--1576191,
InsiderMonkey,Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450,https://insidermonkey.com/blog/--1576192,
InsiderMonkey,RBC Capital Raises PT on Boston Scientific Corporation (BSX) to $125 From $120,https://insidermonkey.com/blog/--1576193,
